In Cameroon and Malawi, the CF approach using both CRP and AGP significantly (P < 0.05) reduced the estimated prevalence of deficiency by 13.1 and 9.6 pp, respectively (Figure 3). The gene discussed is ATP5MK; the disease is cystic fibrosis.